WASHINGTON — There’s an unlikely kumbaya in Washington this year: both President Trump and House Speaker Nancy Pelosi have made it clear that lowering the cost of prescription drugs is among their top priorities.

But with a fiercely resistant pharmaceutical lobby, an unpredictable White House, and split control of Congress, can 2019 be the year something finally gets done?

STAT’s Washington correspondents Lev Facher and Nicholas Florko explore these questions and fielded more on this hot-button issue.

advertisement

Download slides here (PDF). You may view the webinar recording below.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I CAME TO YOUR SITE TO RETRIEVE SLIDES AND ACCESS THE VIDEO WEBINAR ONLY TO FIND THAT THE ONLY WAY TO ACCESS THESE WAS TO JOIN STAT PLUS!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy